Français
ItalianoBond Royalty Pharma 3.3% ( US78081BAL71 ) in USD
| Issuer | Royalty Pharma | ||||
| Market price |  100.00 % ▲ |
||||
| Country |  United States
|
||||
| ISIN code |
 US78081BAL71 ( in USD )
|
||||
| Interest rate | 3.3% per year ( payment 2 times a year) | ||||
| Maturity | 02/09/2040 | ||||
|
Prospectus brochure in PDF format |
|||||
| Minimal amount | 2 000 USD | ||||
| Total amount | 1 000 000 000 USD | ||||
| Cusip | 78081BAL7 | ||||
| Standard & Poor's ( S&P ) rating | BBB- ( Lower medium grade - Investment-grade ) | ||||
| Moody's rating | Baa3 ( Lower medium grade - Investment-grade ) | ||||
| Next Coupon | 02/03/2027 ( In 167 days ) | ||||
| Detailed description |
Royalty Pharma is a biopharmaceutical company that invests in and manages royalties from marketed pharmaceutical and biotechnology products. The Bond issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAL71, pays a coupon of 3.3% per year. The coupons are paid 2 times per year and the Bond maturity is 02/09/2040 The Bond issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAL71, was rated Baa3 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAL71, was rated BBB- ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||
| |||||